OSIS on Nasdaq

OSI Systems

American electronics company

OSI Systems, Inc. is an American company based in California that develops and markets security and inspection systems such as airport security X-ray machines and metal detectors, medical monitoring and anesthesia systems, and optoelectronic devices. As of June 2010, the company employs approximately 3,180 personnel globally and includes subsidiary companies Spacelabs Healthcare, Rapiscan Systems and OSI Optoelectronics.3 Its shares trade on Nasdaq under the symbol OSIS.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

$1.8BRevenue, fiscal 20265
$154.7MNet income, fiscal 20265
1987Founded1

Compare with Cirrus Logic, Tower Semiconductor Ltd. or Ultra Clean Holdings, Inc., or pick any stock.

  • TickerOSIS on Nasdaq1
  • IndustrySemiconductors & Related Devices1
  • HeadquartersHawthorne1
  • Websitewww.osi-systems.com
  • Legal formDelaware corporation1
  • Incorporated inDE6
  • Business address12525 Chadron Ave, Hawthorne, Ca 902506
  • Filer categoryLarge accelerated filer6
  • LEIDDX3MPX1Y8YD30050X334
  • StatusActive4
  • LEI statusIssued and current4
  • Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States4
  • Registered withDivision of Corporations, Department of State, 47890034

OSI Systems, Inc. is an American company based in California that develops and markets security and inspection systems such as airport security X-ray machines and metal detectors, medical monitoring and anesthesia systems, and optoelectronic devices. As of June 2010, the company employs approximately 3,180 personnel globally and includes subsidiary companies Spacelabs Healthcare, Rapiscan Systems and OSI Optoelectronics.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

33.2%Gross margin5
12.3%Operating margin5
8.7%Net margin5
4.3%Revenue growth, 20265
18.6%Return on equity5
1.20×Debt to equity5
$245.3MFree cash flow5

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Product brought in 73% of the revenue OSI Systems broke down this way in fiscal 2026.

  1. Product$1.3B573%up 2% from 2025
  2. Service$441.3M524%up 13% from 2025
  3. Bill and Hold Service$64.7M53%up 239% from 2025
Products and services by year
Products and services202420252026
Product$1.2B$1.3B$1.3B
Service$331.2M$389.9M$441.3M
Bill and Hold Service$5.5M$19.1M$64.7M

Business segments

Security Division brought in 67% of the revenue OSI Systems broke down this way in fiscal 2026.

  1. Security Division$1.2B567%up 4% from 2025
  2. Optoelectronics And Manufacturing Division$450.8M524%up 9% from 2025
  3. Healthcare Division$162.7M59%down 3% from 2025
Business segments by year
Business segments202420252026
Security Division$1.0B$1.2B$1.2B
Optoelectronics And Manufacturing Division$384.3M$412.1M$450.8M
Healthcare Division$171.4M$168.4M$162.7M

Regions

United States brought in 33% of the revenue OSI Systems broke down this way in fiscal 2026.

  1. United States$583.2M533%up 4% from 2025
  2. United Kingdom$503.5M528%up 35% from 2025
  3. Asia Pacific$316.4M518%up 7% from 2025
  4. Other Americas$205.9M512%up 33% from 2025
  5. Mexico$99.1M56%down 64% from 2025
  6. Other EMEA$77.9M54%up 56% from 2025
Regions by year
Regions202420252026
United States$527.1M$563.0M$583.2M
United Kingdom$234.9M$373.0M$503.5M
Asia Pacific$242.0M$295.7M$316.4M
Other Americas$61.6M$155.1M$205.9M
Mexico$423.2M$276.3M$99.1M
Other EMEA$50.0M$50.0M$77.9M

Where the money goes

Where each dollar of revenue went, fiscal 2026

  • Cost of revenue67¢$1.2B
  • Research and development4¢$79.1M
  • Selling, general and admin16¢$278.4M
  • Other costs2¢$42.8M
  • Income tax2¢$38.0M
  • Profit9¢$154.7M

Out of $1.8B in revenue.5

Where each dollar of operating cash went, fiscal 2026

  • Capital spending10¢$30.6M
  • Share buybacks90¢$271.9M

Out of $275.9M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.5

Financial statements

Revenue9101112135$1.8B in 2026+51% since 2019
0$500.0M$1.0B$1.5B$2.0B2019: $1.2B$1.2B20192020: $1.2B$1.2B2020−1%2021: $1.1B$1.1B2021−2%2022: $1.2B$1.2B2022+3%2023: $1.3B$1.3B2023+8%2024: $1.5B$1.5B2024+20%2025: $1.7B$1.7B2025+11%2026: $1.8B$1.8B2026+4%
Gross profit9101112135$593.1M in 2026+38% since 2019
0$200.0M$400.0M$600.0M2019: $430.6M$430.6M20192020: $420.6M$420.6M2020−2%2021: $419.9M$419.9M2021−0%2022: $424.4M$424.4M2022+1%2023: $430.5M$430.5M2023+1%2024: $530.5M$530.5M2024+23%2025: $587.2M$587.2M2025+11%2026: $593.1M$593.1M2026+1%
Operating income9101112135$219.0M in 2026+103% since 2019
0$100.0M$200.0M$300.0M2019: $107.8M$107.8M20192020: $104.9M$104.9M2020−3%2021: $115.4M$115.4M2021+10%2022: $121.7M$121.7M2022+6%2023: $135.3M$135.3M2023+11%2024: $189.1M$189.1M2024+40%2025: $217.5M$217.5M2025+15%2026: $219.0M$219.0M2026+1%
Net income9101112135$154.7M in 2026+139% since 2019
0$50.0M$100.0M$150.0M$200.0M2019: $64.8M$64.8M20192020: $75.3M$75.3M2020+16%2021: $74.0M$74.0M2021−2%2022: $115.3M$115.3M2022+56%2023: $91.8M$91.8M2023−20%2024: $128.2M$128.2M2024+40%2025: $149.6M$149.6M2025+17%2026: $154.7M$154.7M2026+3%

Every line of the income statement as filed: the last 3 fiscal years (annual) or 8 quarters (quarterly), latest first.5

Period ending2026-06-302025-06-302024-06-30
Total net revenues$1.8B$1.7B$1.5B
Total cost of goods sold$1.2B$1.1B$1.0B
Gross profit$593.1M$587.2M$530.5M
Selling, general and administrative$278.4M$290.9M$269.7M
Research and development$79.1M$73.4M$65.3M
Impairment, restructuring and other charges$16.6M$5.3M$6.4M
Total operating expenses$374.1M$369.7M$341.4M
Income from operations$219.0M$217.5M$189.1M
Interest and other expense, net-$26.2M-$31.4M-$27.8M
Income before income taxes$192.7M$186.1M$161.2M
Provision for income taxes-$38.0M-$36.5M-$33.1M
Net income$154.7M$149.6M$128.2M
Basic (in dollars per share)$9.33$8.93$7.55
Diluted (in dollars per share)$8.95$8.71$7.38
Basic (in shares)16.6M shares16.8M shares17.0M shares
Diluted (in shares)17.3M shares17.2M shares17.4M shares

Compare OSI Systems with another company

Corporate structure

OSI Systems sits at the top of its group. 72 entities, 30 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of OSI Systems

  • OSI Systems Hawthorne, California, United States
    • Altaflex Subsidiary · California, United States
    • American Science and Engineering Global de Mexico S. de R.L. de C.V. Subsidiary · Mexico
    • American Science and Engineering, Inc. Subsidiary · Massachusetts, United States
    • AS&E Global, Inc. Subsidiary · Massachusetts, United States
    • Aviation Security Management, LLC Subsidiary · Florida, United States
    • Chassis Engineering Limited Subsidiary · United Kingdom
    • Continental Electronics Corporation Subsidiary · Nevada, United States
    • Control de Accessos y Seguridad Privada Gatekeeper, S. de R.L. de C.V. Subsidiary · Mexico
    • Control Insights, LLC Subsidiary · California, United States
    • CXR Limited Subsidiary · United Kingdom
    • ECIL-Rapiscan Security Products Limited Subsidiary · India
    • Gatekeeper Inc. Subsidiary · Delaware, United States
    • Gatekeeper Inspection Technologies LLC Subsidiary · Virginia, United States
    • Gatekeeper Security Middle East FTZ Subsidiary · United Arab Emirates
    • Global International Holding, Inc. Subsidiary · Delaware, United States
    • Lenview Limited Subsidiary · United Kingdom
    • Lenview Property Development (Biddulph) Limited Subsidiary · United Kingdom
    • OSI (Holdings) Company Limited Subsidiary · United Kingdom
    • OSI Billerica Holdings, LLC Subsidiary · Massachusetts, United States
    • OSI Electronics (UK) Ltd. Subsidiary · United Kingdom
    • OSI Electronics de Mexico, S.A. de C.V. Subsidiary · Mexico
    • OSI Electronics Pte Ltd. Subsidiary · Singapore
    • OSI Electronics Sdh. Bhd. Subsidiary · Malaysia
    • OSI Investment Egypt For Trading LLC Subsidiary · Egypt
    • OSI Optoelectronics Sdn. Bhd. Subsidiary · Malaysia
    • and 46 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What OSI Systems reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$321.6M5 Jun 30, 2026$311.6M5 Jun 30, 2025+3.2%
Accumulated depreciation$191.6M5 Jun 30, 2026$184.8M5 Jun 30, 2025+3.7%
Property and equipment, net$129.9M5 Jun 30, 2026$126.7M5 Jun 30, 2025+2.5%
Operating-lease assets (leased space)$47.9M5 Jun 30, 2026$32.0M5 Jun 30, 2025+49.4%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$359.8M5 Jun 30, 2026$106.4M5 Jun 30, 2025+238.2%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$406.7M5 Jun 30, 2026$387.4M5 Jun 30, 2025+5.0%
Intangible assets, net (excluding goodwill)$192.4M5 Jun 30, 2026$183.3M5 Jun 30, 2025+4.9%
Finite-lived intangibles, gross$191.9M5 Jun 30, 2026$221.9M5 Jun 30, 2025−13.5%
Accumulated amortization$41.9M5 Jun 30, 2026$78.5M5 Jun 30, 2025−46.7%
Finite-lived intangibles, net$150.0M5 Jun 30, 2026$143.4M5 Jun 30, 2025+4.6%

Inventory

ItemLatestA year beforeChange
Inventory, total$415.6M5 Jun 30, 2026$407.2M5 Jun 30, 2025+2.1%
Raw materials$261.6M5 Jun 30, 2026$246.0M5 Jun 30, 2025+6.4%
Work in process$77.3M5 Jun 30, 2026$72.1M5 Jun 30, 2025+7.2%
Finished goods$76.6M5 Jun 30, 2026$89.1M5 Jun 30, 2025−14.0%

Properties, in its own words

As of June 30, 2026, we owned the following principal facilities:

Approximate

The rest of Item 2

Square

Location · Description of Facility · Footage

Billerica, Massachusetts · Manufacturing, engineering, sales and marketing and service for our Security division · 186,200

Snoqualmie, Washington · Headquarters and administrative, manufacturing, engineering, sales, marketing and service for our Healthcare division · 177,000

Batam, Indonesia · Manufacturing for our Optoelectronics and Manufacturing division · 93,500

Stoke on Trent, United Kingdom · Manufacturing, engineering, sales, marketing and service for our Security division · 90,000

Surrey, United Kingdom · Manufacturing, engineering, sales, marketing and service for our Security division · 59,000

As of June 30, 2026, we leased the following principal facilities:

Approximate

Location · Description of Facility · Square Footage · Expiration

Dallas, Texas · Manufacturing, engineering, sales and marketing and service for our Security division · 119,400 · 2026

Hawthorne, California · Corporate headquarters and administrative, manufacturing, engineering, sales and marketing and service for our Optoelectronics and Manufacturing division · 88,000 · 2027

Torrance, California · Manufacturing, engineering, sales and marketing and service for our Security division · 91,900 · 2027

Batam, Indonesia (1) · Manufacturing for our Optoelectronics and Manufacturing division · 101,200 · 2027 ~ 2028

Johor Bahru, Malaysia(1) · Manufacturing, engineering, sales and service for our Optoelectronics and Manufacturing division · 110,100 · 2027 ~ 2028

Johor Bahru, Malaysia(1) · Manufacturing, engineering, sales and service for our Security division · 167,600 · 2028

Dallas, Texas · Manufacturing and engineering for our Security division · 102,300 · 2035

(1) · This is comprised of multiple leases at the same or nearby facilities.

We believe that our facilities are in adequate condition to support our current operations but expect to expand as necessary to support our anticipated future growth. We currently anticipate that we will be able to renew the leases that are scheduled to expire in the next few years on terms that are substantially the same as those currently in effect. However, even if we were not able to renew one or more of the leases, we believe that suitable substitute space is available to relocate any of the facilities. Accordingly, we do not believe that our failure to renew any of the leases that are scheduled to expire in the next few years will have a material adverse effect on our operations.

Item 2 of the 10-K filed Aug 21, 2026.17

The story

1987 OSI Systems, Inc. was founded (prior to May 1997 operated under the name “Opto Sensors, Inc.”)

1990 Acquired UDT Sensors, Inc.

1993 Acquired Rapiscan Security Products Limited

1993 Acquired Ferson Optics, Inc.

1994 Formed ECIL-Rapiscan Security Products Limited (partnership with Electronics Corporation Of India Limited)

1994 Formed Opto Sensors (Malaysia) Sdn. Bhd.

1997 Acquired Advanced Micro Electronics AS

1998 Acquired Osteometer MediTech A/S

Read the full text

1998 Purchased the security products business of Metorex International Oy

1998 Purchased a minority equity stake in Square One, Inc., (In 2000, acquired substantially all of Square One, Inc.’s assets)

1999 Acquired Aristo Medical Products, Inc.

1999 Formed OSI Medical, Inc.

2000 Formed RapiTec, Inc.

2001 Formed Dolphin Medical (merged OSI Medical, Inc. into Dolphin in March 2002)

2002 Acquired substantially all the assets of Thermo Centro Vision, Inc.,

2002 Purchased a minority equity interest in CXR Limited, (In December 2004 CXR Limited became a wholly owned subsidiary)

2002 Acquired all the outstanding capital stock of Ancore Corporation

2003 Acquired the military, laser-based training business of Schwartz Electro-Optics, Inc. (In November 2003, acquired substantially all remaining assets of Schwartz Electro-Optics, Inc.)

2003 Acquired substantially all of the assets of J&D Engineering (UK) Limited.

2004 Acquired Spacelabs Medical.

2005 Acquired Blease Medical Holdings Limited.

2006: OSI acquires Del Mar Reynolds, the British diagnostic cardiology company and adds it to the healthcare organization.

2011 Established new office in Hitech City in Hyderabad.

2016 The company offered $269 million to acquire American Science and Engineering, a US manufacturer of X-ray equipment.

2022 Establishes New State of the Art Factory of 50K sq. ft. near RG International Airport (RGIA), Hyderabad India specializing in manufacturing of medical devices

From Wikipedia’s article on OSI Systems, shared under CC BY-SA 4.0.7

Leadership

Who has led OSI Systems, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (26)

Subsidiaries and ownership

Subsidiaries

Subsidiaries (Exhibit 21)

  • AS&E Global, Inc. Massachusetts8
  • Altaflex California8
  • American Science and Engineering Global de Mexico S. de R.L. de C.V. Mexico8
  • American Science and Engineering, Inc. Massachusetts8
  • Aviation Security Management, LLC Florida8
  • CXR Limited United Kingdom8
  • Chassis Engineering Limited United Kingdom8
  • Continental Electronics Corporation Nevada8
  • Control Insights, LLC California8
  • Control de Accessos y Seguridad Privada Gatekeeper, S. de R.L. de C.V. Mexico8
  • ECIL-Rapiscan Security Products Limited India8
  • Gatekeeper Inc. Delaware8
  • Gatekeeper Inspection Technologies LLC Virginia8
  • Gatekeeper Security Middle East FTZ United Arab Emirates8
  • Global International Holding, Inc. Delaware8
  • Lenview Limited United Kingdom8
  • Lenview Property Development (Biddulph) Limited United Kingdom8
  • OSI (Holdings) Company Limited United Kingdom8
  • OSI Billerica Holdings, LLC Massachusetts8
  • OSI Electronics (UK) Ltd. United Kingdom8
  • OSI Electronics Pte Ltd. Singapore8
  • OSI Electronics Sdh. Bhd. Malaysia8
  • OSI Electronics de Mexico, S.A. de C.V. Mexico8
  • OSI Electronics, Inc. California8
All 82 listed subsidiaries
  • OSI Investment Egypt For Trading LLC Egypt8
  • OSI Optoelectronics Sdn. Bhd. Malaysia8
  • OSI Optoelectronics, Inc. California8
  • OSI Systems Private Limited India8
  • PFC Flexible Circuits Limited Canada8
  • PT OSI Electronics Indonesia8
  • PT OSI Systems Indonesia8
  • Quadratica (UK) Limited United Kingdom8
  • RAGGI-X Manutenção em Equipamentos Electrônicos LTDA Brazil8
  • RAPISCAN SYSTEMS TURKEY GÜVENLİK TEKNOLOJİLERİ ANONİM ŞİRKETİ. Turkey8
  • Rapiscan Australia Pty Ltd Australia8
  • Rapiscan Government Services, Inc. Delaware8
  • Rapiscan Holdings Inc / Jordan Jordan8
  • Rapiscan Holdings, Inc. Delaware8
  • Rapiscan Laboratories, Inc. Delaware8
  • Rapiscan Mexico Holdings LLC Delaware8
  • Rapiscan Services Egypt LLC Egypt8
  • Rapiscan Systems (Private) Limited Sri Lanka8
  • Rapiscan Systems Canada Inc. Canada8
  • Rapiscan Systems GmbH Germany8
  • Rapiscan Systems Hong Kong Limited Hong Kong8
  • Rapiscan Systems Limited United Kingdom8
  • Rapiscan Systems Mexico S. de R.L. de C.V. Mexico8
  • Rapiscan Systems Middle East Regional Headquarters Company LCC Saudi Arabia8
  • Rapiscan Systems New Zealand New Zealand8
  • Rapiscan Systems Private Limited India8
  • Rapiscan Systems Pte. Ltd. Singapore8
  • Rapiscan Systems Pty Ltd Australia8
  • Rapiscan Systems Sdn. Bhd. Malaysia8
  • Rapiscan Systems Turkmen Turkmenistan8
  • Rapiscan Systems, Inc. California8
  • Rapiscan Systems, S.A. de C.V. Mexico8
  • Rapiscan Systems, Unipessoal LDA Portugal8
  • S2 Airport Services S. de R.L. de C.V. Mexico8
  • S2 Albania Albania8
  • S2 Global Ecuador S.A.S. Ecuador8
  • S2 Global Healthcare, S. de R.L. de C.V. Mexico8
  • S2 Global Panama, S.A. Panama8
  • S2 Global SAL Lebanon8
  • S2 Global Screening Solutions Limited Ireland8
  • S2 Global Screening Solutions Sociedad Anonima Guatemala8
  • S2 Global, Inc. Delaware8
  • S2 Muscat LLC Oman8
  • S2 Screening Solutions, S. de R.L. de C.V. Mexico8
  • S2 Secure Albania SH.P.K. Albania8
  • S2 Security, LLC Delaware8
  • S2 Services Puerto Rico, LLC Puerto Rico8
  • S2 Services, Ltd. Cayman Islands8
  • Spacelabs Healthcare (Canada), Inc. Canada8
  • Spacelabs Healthcare GmbH Germany8
  • Spacelabs Healthcare Limited United Kingdom8
  • Spacelabs Healthcare Pte. Ltd. Singapore8
  • Spacelabs Healthcare SAS France8
  • Spacelabs Healthcare s.r.l. Italy8
  • Spacelabs Healthcare, Inc. Delaware8
  • Spacelabs Healthcare, L.L.C. Washington8
  • Spacelabs Holdings, Inc. Delaware8
  • Surveillance Health, LLC Washington8

From Wikidata.1 The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • OSI SYSTEMS INCOct 3, 1997 to Aug 26, 20266

Timeline

  1. Aug 20, 20268-K Results of operations; Other events50
  2. May 4, 20268-K Results of operations51
  3. Jan 29, 20268-K Results of operations52
  4. Dec 11, 20258-K Shareholder vote53
  5. Nov 20, 20258-K Entered a material agreement; New debt or obligation; Unregistered sale of shares54
  6. Nov 18, 20258-K Other events55
  7. Nov 17, 20258-K Other events56
  8. Oct 30, 20258-K Results of operations57
  9. Aug 21, 20258-K Results of operations58
  10. Jul 2, 20258-K Entered a material agreement; New debt or obligation59
  11. May 28, 20258-K Executive or director change60
  12. May 1, 20258-K Results of operations61
  13. Jan 2, 2025New chief executive Ajay Mehra becomes CEO18
  14. Oct 2, 1997Went public Listed on NASDAQ1
  15. 1987Founded Founded1

Calendar

Coming up

  1. Oct 29, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $1.42 a share, on Oct 30, 2025.62

When it reported results

  1. Aug 20, 2026Reported quarterly or annual results50
  2. May 4, 2026Reported quarterly or annual results51
  3. Jan 29, 2026Reported quarterly or annual results52
  4. Oct 30, 2025Reported quarterly or annual results57
  5. Aug 21, 2025Reported quarterly or annual results58
  6. May 1, 2025Reported quarterly or annual results61
  7. Jan 23, 2025Reported quarterly or annual results63
  8. Oct 24, 2024Reported quarterly or annual results64

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

490 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 40 major events, 321 insider forms, 28 large holders, 81 other. The latest 20:

  1. Aug 26, 20264 EDGAR
  2. Aug 26, 20264 EDGAR
  3. Aug 26, 20264 EDGAR
  4. Aug 26, 20264 EDGAR
  5. Aug 25, 20264 EDGAR
  6. Aug 25, 20264 EDGAR
  7. Aug 25, 20264 EDGAR
  8. Aug 25, 20264 EDGAR
  9. Aug 25, 20264 EDGAR
  10. Aug 21, 20264 EDGAR
  11. Aug 21, 20264 EDGAR
  12. Aug 21, 202610-K EDGAR
  13. Aug 21, 20264 EDGAR
  14. Aug 21, 20264 EDGAR
  15. Aug 20, 20268-K EDGAR
  16. Aug 17, 20264 EDGAR
  17. Aug 17, 20264 EDGAR
  18. Aug 17, 20264 EDGAR
  19. Aug 13, 2026SCHEDULE 13G EDGAR
  20. Aug 6, 2026SCHEDULE 13G/A EDGAR

The 490 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

99 open-market trades by officers, directors and large owners since October 2021: 0 buys and 99 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
May 4, 2026CHOPRA DEEPAKDirectorSale20,000$281.84$5.6MForm 4
Feb 2, 2026CHOPRA DEEPAKDirectorSale20,000$250.91$5.0MForm 4
Nov 10, 2025CHOPRA DEEPAKDirectorSale20,000$285.74$5.7MForm 4
Nov 7, 2025Morben Paul KeithPRES., OPTOELECTRONICS DIVSale416$279.10$116.1KForm 4
Nov 7, 2025HAWKINS JAMES BDirectorSale1,500$283.15$424.7KForm 4
Oct 1, 2025CHOPRA DEEPAKDirectorSale20,000$245.80$4.9MForm 4
Sep 12, 2025Ballhaus William Francis JRDirectorSale562$237.84$133.7KForm 4
Sep 4, 2025Morben Paul KeithPRES., OPTOELECTRONICS DIVSale1,671$236.76$395.6KForm 4
Jun 12, 2025LUSKIN MEYER/DirectorSale1,000$237.15$237.2KForm 4
May 21, 2025Ballhaus William Francis JRDirectorSale750$228.88$171.7KForm 4
May 13, 2025EDRICK ALAN IEVP & CFOSale20,000$229.00$4.6MForm 4
May 8, 2025Grindstaff GlennCHIEF HUMAN RESOURCES OFFICERSale688$224.89$154.7KForm 4
May 6, 2025Ballhaus William Francis JRDirectorSale933$219.77$205.0KForm 4
May 6, 2025CHOPRA DEEPAKDirectorSale5,000$220.11$1.1MForm 4
May 5, 2025CHOPRA DEEPAKDirectorSale20,000$221.79$4.4MForm 4
Feb 4, 2025CHOPRA DEEPAKDirectorSale20,000$198.26$4.0MForm 4
Feb 3, 2025CHOPRA DEEPAKDirectorSale20,000$193.55$3.9MForm 4
Jan 30, 2025Morben Paul KeithPRES., OPTOELECTRONICS DIVSale155$199.36$30.9KForm 4
Jan 27, 2025CHIZEVER GERALD MDirectorSale2,701$195.83$528.9KForm 4
Dec 13, 2024EDRICK ALAN IEVP & CFOSale7,646$188.00$1.4MForm 4

All 99 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Ajay MehraPresident and Chief Executive Officer63$621.4K$7.5M72
2025Deepak ChopraExecutive Chairman of the Board74$664.4K$4.6M72
2025Alan EdrickExecutive Vice President and Chief Financial Officer57$534.1K$3.3M72
2025Victor S. SzeExecutive Vice President, General Counsel and Secretary58$461.0K$2.6M72
2025Paul MorbenPresident of Optoelectronics and Manufacturing Division64$330.3K$727.2K72
2025Manoocher MansouriChief Technology Officer of Optoelectronics and Manufacturing Division69$334.5K$600.9K72
2024Deepak ChopraExecutive Chairman of the Board74$1.0M$20.7M72
2024Ajay MehraPresident and Chief Executive Officer63$492.3K$5.8M72
2024Alan EdrickExecutive Vice President and Chief Financial Officer57$519.1K$3.1M72
2024Victor S. SzeExecutive Vice President, General Counsel and Secretary58$448.1K$2.5M72
2024Manoocher MansouriChief Technology Officer of Optoelectronics and Manufacturing Division69$328.6K$778.5K72
2023Deepak ChopraExecutive Chairman of the Board74$995.0K$8.1M72
2023Ajay MehraPresident and Chief Executive Officer63$477.7K$4.0M72
2023Alan EdrickExecutive Vice President and Chief Financial Officer57$503.7K$3.0M72
2023Victor S. SzeExecutive Vice President, General Counsel and Secretary58$434.8K$2.5M72
2023Manoocher MansouriChief Technology Officer of Optoelectronics and Manufacturing Division69$318.8K$785.1K72

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.2,552,027$558.1M0.0%+22,404
Fmr LLC1,738,166$380.1M0.0%−228,922
Vanguard Portfolio Management LLC1,272,016$278.2M0.0%+22,268
Jupiter Topco LLC905,925$198.1M0.1%New
Vanguard Capital Management LLC703,070$153.8M0.0%+3,817
State Street Corp674,053$147.4M0.0%+11,912
Capital International Investors596,331$130.4M0.0%−23,148
Geode Capital Management, LLC463,787$101.4M0.0%+23,064
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC452,547$99.0M0.0%+21,986
Channing Capital Management, LLC432,851$94.7M2.2%+165,967
Hood River Capital Management LLC414,304$90.6M0.7%+42,230
Dimensional Fund Advisors LP414,034$90.5M0.0%+18,606
William Blair Investment Management, LLC379,351$83.0M0.2%+207,684
Neuberger Berman Group LLC324,715$70.9M0.0%+20,792
Millennium Management LLC298,480$65.3M0.0%+254,870
Invesco Ltd.263,207$57.6M0.0%−110,067
Primecap Management Co/ca/258,180$56.5M0.0%+13,520
American Century Companies Inc223,142$48.8M0.0%+172,148
Neumeier Poma Investment Counsel LLC222,515$48.7M3.3%+31,085
Clark Capital Management Group, Inc.218,913$47.9M0.3%−51,507
Systematic Financial Management LP216,098$47.3M0.9%−3,143
UBS Group AG210,866$46.1M0.0%+74,905
Van Eck Associates Corp199,636$43.7M0.0%+11,456
Morgan Stanley197,990$43.3M0.0%−12,387
Charles Schwab Investment Management Inc193,801$42.4M0.0%−7,185

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How OSI Systems is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGAROSI SYSTEMS INC2
  • CIK0001039065
  • Employer ID (EIN)33-023880117
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company17
  • Incorporated inDelaware17
  • Fiscal year endsJune 302
  • Industry code (SIC)3674 Semiconductors & Related Devices2
  • SEC reviewing officeOffice of Manufacturing, Division of Corporation Finance2
  • Business address12525 Chadron Ave, Hawthorne, CA 902502
  • Mailing address12525 Chadron Avenue, Hawthorne, CA 902502
  • Phone31097805162
  • Shares outstanding15,941,968 shares as of Aug 17, 202617
  • Public float$4.0B as of Dec 31, 202517
  • AuditorGRANT THORNTON LLP, Los Angeles, California PCAOB ID 248; it also attests to the company’s internal control over financial reporting17
  • On EDGAR sinceJun 13, 19972
  • Filings1,964 in all: 4 (1,119), 8-K (217), SC 13G/A (107), 10-Q (87), 144 (62), SC 13G (47), 3 (35), 10-K (29)2
    All 43 form types

    DEF 14A (28), UPLOAD (28), 5 (20), 4/A (19), DEFA14A (19), CORRESP (18), S-8 (13), SD (13), SCHEDULE 13G/A (12), 8-K/A (11), ARS (10), EFFECT (7), S-8 POS (7), POS AM (6), S-3 (6), SCHEDULE 13G (5), 8-A12G/A (4), PRE 14A (4), S-3/A (4), NT 10-K (3), NT 10-Q (3), S-1/A (3), 10-K/A (2), 3/A (2), 424B3 (2), 8-A12G (2), CT ORDER (2), 424A (1), 424B1 (1), 5/A (1), 8-K12G3 (1), DEFR14A (1), S-1 (1), SC 14N (1), SC TO-C (1)

  • Latest filingsAnnual report (10-K) Aug 21, 2026
    Quarterly report (10-Q) May 4, 2026
    Proxy statement (DEF 14A) Oct 22, 2025
    Latest 8-K (8-K) Aug 20, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, $0.001 par valueOSISThe Nasdaq Global Select Market

From the cover page of the 10-K filed Aug 21, 2026 (Section 12(b) of the Exchange Act).17

Risk factors and legal proceedings

The risks OSI Systems names in Item 1A of its 10-K filed Aug 21, 2026: 48 risks under these headings, as written.17

  • Business and Industry Risks
  • If operators of, or algorithms installed on, our security and inspection systems fail to detect weapons, explosives or other devices or materials that are used to commit a crime, terrorist act or other mass casualty event, we could be exposed to product and professional liability and related claims for which we may not have adequate insurance coverage.
  • The loss of certain of our customers, including government agencies that can modify or terminate agreements more easily than other commercial customers with which we contract, the failure to continue to diversify our customer base or the non-renewal of certain material contracts could have a negative effect on our reputation and could have a material adverse effect on our business, financial condition and results of operations.
  • Our acquisition and alliance activities could result in disruption of our ongoing business and other operational difficulties, unrecoverable costs, and other negative consequences, any of which could adversely impact our financial condition and results of operations.
  • Substantial declines in crude oil prices or extended periods of low crude oil prices may adversely affect our business, financial condition, and results of operations.
  • Unfavorable currency exchange rate fluctuations could adversely affect our financial results.
  • U.S. budgeting process disruptions could reduce government spending, which could adversely impact our revenues, earnings, cash flows and financial condition.
  • We face aggressive competition in each of our operating divisions. If we do not compete effectively, our business will be harmed.
  • Healthcare cost containment pressures and legislative or regulatory reforms may affect our ability to sell our products profitably.
  • Consolidation in the healthcare industry could have a material and adverse effect on our revenues and results of operations.
  • Technological advances and evolving regulatory standards could reduce our future product sales, which could cause our revenues to grow more slowly or decline.
  • Certain of our government contracts are dependent upon our employees obtaining and maintaining required security clearances, as well as our ability to obtain security clearances for the facilities in which we perform sensitive government work.
The other 37 risks
  • We could be subject to changes in tax rates, the adoption of new U.S. or international tax legislation, or exposure to additional tax liabilities.
  • Geopolitical instability and conflicts in the Middle East could adversely affect our operations, supply chain, and financial performance.
  • We cannot predict the consequences of current or future geopolitical events, but they may adversely affect the markets in which we operate and our results of operations.
  • Operational Risks
  • As a U.S. Government contractor, we are subject to extensive Federal procurement rules and regulations as well as contractual obligations that are unique to doing business with the U.S. Government. Non-compliance with any such rules, regulations or contractual obligations could negatively affect current programs, potential awards and our ability to do business with the U.S. Government in the future.
  • Due to the competitive process to obtain contracts and the likelihood of protests, we may be unable to achieve or sustain revenue growth and profitability.
  • Our revenues are dependent on orders of security and inspection systems, turnkey security screening solutions and patient monitoring and cardiology and remote monitoring systems, which may have lengthy and unpredictable sales cycles.
  • If we do not introduce new products in a timely manner, our products could become obsolete and our operating results would suffer.
  • Increased prices for, and interruptions in our ability to purchase, raw materials and subcomponents may adversely affect our profitability.
  • We contract with third parties that may be unable to fulfill contracts on time.
  • We accumulate excess quantities or elevated inventory levels from time to time.
  • Economic, political, legal, operational and other risks associated with international sales and operations could adversely affect our financial performance.
  • There are inherent risks associated with operations in Mexico.
  • Our operations are vulnerable to interruption or loss due to natural disasters, epidemics or pandemics such as COVID-19, terrorist acts and other events beyond our control, which could adversely impact our operations.
  • Any recall of our products, either voluntarily or at the direction of the FDA or another governmental authority, or the discovery of serious safety issues with our products that leads to corrective actions, could have a material adverse impact on us.
  • We rely on third parties and our own systems for interaction with our customers and suppliers and employees, and a failure of a key information technology system, process or site or any other failure or interruption in the services provided by these third parties or our own systems could have a material adverse impact on our ability to conduct business.
  • We could suffer a loss of revenue and increased costs, exposure to significant liability, reputational harm, and other serious negative consequences if we sustain cyber-attacks or other data security breaches that disrupt our operations or result in the dissemination of proprietary or confidential information about us or our customers, suppliers, or other third parties; our products and services may be subject to potential cyber-attacks or other information technology vulnerabilities.
  • Delays, costs, and disruptions that result from upgrading, integrating and maintaining the security of our information and technology networks and systems could materially and adversely affect us.
  • Our inability to successfully manage the implementation of a company-wide enterprise resource planning (“ERP”) system could adversely affect our operating results.
  • Our credit facility contains provisions that could restrict our ability to finance our future operations or engage in other business activities that may be in our interest.
  • Shares of our common stock issuable upon conversion of the 2.25% Convertible Senior Notes due 2029 (the “2029 Notes”) or the 0.50% Convertible Senior Notes due 2031 (the “2031 Notes”), collectively the “Notes”, may dilute the ownership interest of our stockholders or may adversely affect the market price of our common stock.
  • Our indebtedness (including the Notes) could limit the cash flow available for our operations, expose us to risks that could adversely affect our business, financial condition and results of operations and impair our ability to satisfy our debt obligations, including the Notes.
  • We may be unable to raise the funds necessary to repurchase the Notes for cash following a fundamental change, or to pay the cash amounts due upon conversion, and our other indebtedness may limit our ability to repurchase the Notes or pay cash upon their conversion.
  • Provisions in the Note Indenture could delay or prevent an otherwise beneficial takeover of us.
  • The accounting method for the Notes could adversely affect our reported financial condition and results.
  • Legal and Regulatory Risks
  • The Support Anti-terrorism by Fostering Effective Technologies Act of 2002 (SAFETY Act) may not shield us against legal claims we may face following an act of terrorism.
  • Our patient monitoring, cardiology and remote monitoring, and connected care systems could give rise to product liability claims and product recall events that could materially and adversely affect our financial condition and results of operations.
  • Our global operations expose us to legal compliance risks related to certain anti-bribery and anti-corruption laws.
  • We are subject to import and export controls that could subject us to liability or impair our ability to compete in international markets.
  • We are facing an increasingly complex international regulatory environment which is constantly changing and if we fail to comply with international regulatory requirements, or are unable to comply with changes to such requirements, our financial performance may be harmed.
  • Substantial government regulation in the United States and abroad may restrict our ability to sell our patient monitoring, cardiology and remote monitoring, and connected care systems, and failure to comply with such laws and regulations may have a material adverse impact on our business.
  • Legislative or regulatory reforms such as the EU Medical Devices Regulation may make it more difficult and costly for us to obtain certification, regulatory clearance, or approval of any future products and to manufacture, market, and distribute our products after certification, clearance, or approval is obtained.
  • We may be subject to fines, penalties, injunctions, or other enforcement actions if we are determined to be promoting the use of our products for unapproved or “off label” uses, resulting in damage to our reputation and business.
  • Our failure to comply with federal, state, and foreign laws and regulations relating to our healthcare business could have a material and adverse effect on our business.
  • Evolving expectations around corporate responsibility practices, specifically related to environmental, social and governance (“ESG”) matters, may expose us to reputational and other risks.
  • General Risks
  • Significant inflation and increasing interest rates could materially and adversely affect our business and financial results.
  • Our insurance coverage may be inadequate to cover all significant risk exposures.
  • We are involved in various litigation matters, which could have a material adverse effect on our business, financial condition or operating results.

Legal proceedings

From time to time, we are subject to litigation, legal proceedings, and claims arising in the ordinary course of our business or otherwise. More information regarding legal proceedings in which we are involved can be found under Note 11, “Commitments and Contingencies” of the Notes to the Consolidated Financial Statements in Item 8, which is incorporated by reference into this Item 3.

The opening of Item 3, Legal Proceedings.17

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
    SEC EDGAROther events
  56. 56
    SEC EDGAROther events
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72